Al Andalous Medical

What Al Andalous Medical does

Al Andalous Medical (legal name Al Andalous Pharmaceutical Industry) is an Egyptian pharmaceutical manufacturer founded in 2001 and headquartered in Egypt. The company produces and distributes approximately 300 generic and branded medications across 18 therapeutic areas — including cardiovascular, gastrointestinal, blood products, neuropathic pain, CNS, genitourinary, anti-gout, anti-infective, blood glucose regulating, dermatological, gynecology, immune related, NSAIDs, psychiatry, respiratory, dietary supplements, cosmeceuticals, and herbal — and is positioned among the top 20 pharmaceutical companies in Egypt.

The company operates its own manufacturing facility in 6th of October City, Giza, established in 2007, which embeds Research and Development and Quality Control departments. Its commercial portfolio is organized around named sub-brands such as Andoderma (cosmeceuticals), Andovit (iron and nutritional supplements), Andogonium (immune-support syrup), Performa (hair regrowth), Ivothyme (herbal respiratory syrup), and Jungle (oral care). The pipeline includes 70+ products already registered and launched, 60+ registered but not yet launched, and 150+ products under registration.

Al Andalous runs a sales-led go-to-market, distributing products through four regional offices that cover all of Egypt via a direct sales force targeting physicians and healthcare professionals, supported by an online registration/login portal for healthcare professionals. A dedicated export division targets international business partnerships. The company is privately held, founder-led by Dr. Mohamed Ibrahim (CEO & Founder), with no disclosed external investors, subsidiaries, M&A activity, or public-market listing.

Name

Al Andalous Medical

Legal name

Al Andalous Pharmaceutical Industry

Website

https://alandalous.org

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Al Andalous Medical is an Egyptian pharmaceutical manufacturer founded in 2001, producing approximately 300 generic and branded medications across 18 therapeutic areas. The company operates its own manufacturing facility and distributes through four regional offices and an export division, serving healthcare professionals across Egypt and select international markets.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Cold, Flu & Cough Remedies (HLAIADAB), OTC, Vitamins & Supplement Management (HSABALAM)

Keywords

• Pharmaceutical manufacturing
• Generic medications
• Therapeutic products
• Cosmeceutical products
• Pharmaceutical distribution

Headquarters

HQ city

Cairo

HQ country

Egypt

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Revenue generated through manufacturing and selling pharmaceutical products across 18 therapeutic areas including cardiovascular, gastrointestinal, blood products, neuropathic pain, CNS, genitourinary, anti-gout, anti-infective, blood glucose regulating, dermatological, gynecology, immune related, NSAIDs, psychiatry, respiratory, dietary supplements, cosmeceuticals, and herbal products. The company has 70+ products registered and launched, 60+ registered but not launched, and 150+ under registration.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Al Andalous Medical is an Egyptian pharmaceutical manufacturer that develops, manufactures, and distributes approximately 300 branded and generic pharmaceutical products across 18 therapeutic areas (cardiovascular, gastrointestinal, blood, neuropathic pain, CNS, genitourinary, anti-gout, anti-infective, blood glucose regulating, dermatological, gynecology, immune-related, NSAIDs, psychiatry, respiratory, dietary supplements, cosmeceuticals, and herbal). The company sells primarily to healthcare professionals across Egypt through 4 regional offices and exports internationally.

Product overview

Al Andalous Medical is an Egyptian pharmaceutical company established in 2001, positioned among the top 20 pharmaceutical companies in Egypt with approximately 300 total products across multiple therapeutic areas. The company operates as a pharmaceutical manufacturer and distributor with a diverse product portfolio organized into multiple product lines: Blockadipine and Cardiotimide (cardiovascular products), Protectopril and Vasodarone (cardiovascular treatments), Andogablin and Andopentene (neuropathic pain products), Andorivaban and Andorasirox (blood products), Constipride and Gastrobiotic (gastrointestinal products), Andovit dietary supplements (Andovit Iron, Andovit Omega), Andoderma cosmeceutical skincare line (sunscreen products, whitening cream, emollient gel, multicare cream), psychiatry products (Amipride, Aripiprex, Depretreve, Durazac, Tudasidone), CNS products (Andovimpamide, Cerebroprove, Divakote, Eslizepine, Parkicapone, Tiratam), genitourinary products (Andagra, Andodaricin, Erovanafil, Sildocare, Tadalong), anti-gout products (Andouristat), anti-infective products (Andodaclata, Andohepasuvir, Talafovir, New-Clav antibiotics), blood glucose products (Bioglita Plus, Glimepiride Plus), dermatological products (Brimondalous, Netlook, Performa, Tarolimus, Zarotex), immune-related products (Andomatoid, Disprelone), NSAIDs (Extragesic, Ricoxitib), and respiratory products (Erdolytic, Ivothyme herbal syrup). The company serves healthcare professionals across Egypt through its pharmaceutical manufacturing and distribution operations.

Differentiator

Problem solved

Functional benefit

Brands

• Andoderma: Cosmeceutical product line including sunscreens, whitening cream, emollient gel, and multicare cream
• Andogonium
• Andovit
• Performa
• Ivothyme
• Jungle

Products and services

• Blockadipine 10 mg Tablets Lercandipine HCl 10 mg antihypertensive calcium channel blocker for cardiovascular treatment, sold to healthcare professionals.
• Blockadipine 20 mg Tablets Lercandipine HCl 20 mg antihypertensive calcium channel blocker for cardiovascular treatment.
• Cardiotimide 5 mg Tablets Torsemide 5 mg antihypertensive loop diuretic for cardiovascular treatment.
• Cardiotimide 20 mg Tablets Torsemide 20 mg antihypertensive loop diuretic for cardiovascular treatment.
• Olmespironova 20/12.5 mg Tablets Olmesartan medoxomil 20 mg + Hydrochlorothiazide 12.5 mg antihypertensive angiotensin receptor blocker (ARB) combination.
• Olmespironova 20/25 mg Tablets Olmesartan medoxomil 20 mg + Hydrochlorothiazide 25 mg antihypertensive ARB combination.
• Protectopril Tablets Perindopril Erbumine 8 mg antihypertensive angiotensin-converting enzyme (ACE) inhibitor.
• Protectopril Plus Tablets Perindopril Erbumine 4 mg + Indapamide Hemihydrate 1.25 mg ACE inhibitor combination antihypertensive.
• Vasodarone 400 mg Tablets Dronedarone 400 mg antiarrhythmic medication for cardiovascular treatment.
• Andogablin 75 mg Capsules Pregabalin 75 mg neuropathic pain agent for treatment of neuropathic pain conditions.
• Andogablin 150 mg Capsules Pregabalin 150 mg neuropathic pain agent for treatment of neuropathic pain conditions.
• Andopentene 300 mg Tablets Gabapentin 300 mg neuropathic pain agent for treatment of neuropathic pain.
• Andopentene 600 mg Tablets Gabapentin 600 mg neuropathic pain agent for treatment of neuropathic pain.
• Alfathromb Tablets Limaprost 5 mcg prostaglandin E1 analogue for blood-related treatments.
• Andorivaban 2.5 mg Tablets Rivaroxaban 2.5 mg anticoagulant Factor Xa inhibitor for blood clot prevention.
• Andorivaban 10 mg Tablets Rivaroxaban 10 mg anticoagulant Factor Xa inhibitor for blood clot prevention.
• Andorivaban 15 mg Tablets Rivaroxaban 15 mg anticoagulant Factor Xa inhibitor for blood clot prevention.
• Andorivaban 20 mg Tablets Rivaroxaban 20 mg anticoagulant Factor Xa inhibitor for blood clot prevention.
• Andorasirox 500 mg Tablets Deferasirox 500 mg iron chelator for treatment of thalassemia.
• Constipride 1 mg Tablets Prucalopride 1 mg laxative for gastrointestinal treatment.
• Constipride 2 mg Tablets Prucalopride 2 mg laxative for gastrointestinal treatment.
• Gastrobiotic 200 mg Tablets Rifaximin 200 mg antidiarrheal for gastrointestinal infections.
• Gastrobiotic 550 mg Tablets Rifaximin 550 mg antidiarrheal for gastrointestinal infections.
• Amiprostone 8 mcg Capsules Lubiprostone 8 mcg laxative for gastrointestinal treatment.
• Amiprostone 24 mcg Capsules Lubiprostone 24 mcg laxative for gastrointestinal treatment.
• Esopiroxan 20 mg DR Capsules Esomeprazole 20 mg proton pump inhibitor for acid-related gastrointestinal conditions.
• Esopiroxan 40 mg DR Capsules Esomeprazole 40 mg proton pump inhibitor for acid-related gastrointestinal conditions.
• Omecarbex 20/1100 mg Capsules Omeprazole 20 mg + Sodium Bicarbonate 1100 mg proton pump inhibitor combination.
• Omecarbex 40/1100 mg Capsules Omeprazole 40 mg + Sodium Bicarbonate 1100 mg proton pump inhibitor combination.
• Nitazode Suspension Nitazoxanide 100 mg / 5 ml antiprotozoal suspension for gastrointestinal infections.
• Nitazode Tablets Nitazoxanide 500 mg antiprotozoal tablets for gastrointestinal infections.
• Vondalous 10 mg Tablets Vonoprazan 10 mg potassium competitive acid blocker (PCAB) for acid-related conditions.
• Vondalous 20 mg Tablets Vonoprazan 20 mg potassium competitive acid blocker (PCAB) for acid-related conditions.
• Andovit Iron Tablets Liposomal Iron 375 mg, Vitamin C 120 mg, Copper 1.5 mg, Folic Acid 0.4 mg iron supplement dietary product.
• Andovit Iron Plus Suspension Liposomal Iron 50 mg, Vitamin B6 0.6 mg and Vitamin B12 0.5 mcg per 1 ml iron supplement suspension.
• Andovit Omega Capsules Omega 3,6,9 Blend 1212 mg dietary supplement for nutritional support.
• Andogonium Syrup Pelargonium Sidoides Powder Extract 13.3 mg / 5 ml immune system support dietary supplement.
• Ivothyme Syrup Thyme herb extract liquid 750 mg and Ivy leaves extract liquid 45 mg herbal syrup for treatment of productive cough associated with the common cold.
• Andoderma Sunscreen Cream Sun protective and moisturizer (SPF 50+) skincare cream.
• Andoderma Sunscreen Lotion Sun protective and moisturizer (SPF 50+) skincare lotion.
• Andoderma Sunscreen Spray Sun protective and moisturizer (SPF 50+) skincare spray.
• Andoderma Whitening Cream Lightening and anti-aging skincare cream.
• Andoderma Multicare Cream Multi-usage skin protection cream (generic of Sudocrem).
• Andoderma Emollient Gel Emollient and protective gel for skin moisturization.
• Jungle Mouthwash Oral hygiene mouthwash product.
• Andovimpamide 50 mg Tablets Lacosamide 50 mg anticonvulsant sodium channel blocker for neurological conditions.
• Andovimpamide 100 mg Tablets Lacosamide 100 mg anticonvulsant sodium channel blocker for neurological conditions.
• Andovimpamide Solution Lacosamide 10 mg / ml anticonvulsant sodium channel blocker solution.
• Andovimpamide Vial Lacosamide 200 mg / 20 ml anticonvulsant sodium channel blocker injection.
• Cerebroprove Oral Solution Citicoline 100 mg / ml neuroprotective oral solution for brain health.
• Dalfarosis Tablets Dalfampridine 10 mg tablets to improve walking in Multiple Sclerosis (MS).
• Divakote 250 mg ER Tablets Valproic Acid 250 mg extended-release anticonvulsant sodium channel blocker.
• Divakote 500 mg ER Tablets Valproic Acid 500 mg extended-release anticonvulsant sodium channel blocker.
• Eslizepine 400 mg Tablets Eslicarbazepine 400 mg anticonvulsant sodium channel blocker.
• Eslizepine 800 mg Tablets Eslicarbazepine 800 mg anticonvulsant sodium channel blocker.
• Parkicapone Tablets Entacapone 200 mg antiparkinson medication.
• Tiratam 500 mg Tablets Levetiracetam 500 mg anticonvulsant SV2A receptor blocker.
• Tiratam 500 mg XR Tablets Levetiracetam 500 mg extended-release anticonvulsant SV2A receptor blocker.
• Tiratam 750 mg Tablets Levetiracetam 750 mg anticonvulsant SV2A receptor blocker.
• Tiratam 750 mg XR Tablets Levetiracetam 750 mg extended-release anticonvulsant SV2A receptor blocker.
• Tiratam 1000 mg Tablets Levetiracetam 1000 mg anticonvulsant SV2A receptor blocker.
• Tiratam Oral Solution Levetiracetam 100 mg / 1 ml anticonvulsant SV2A receptor blocker oral solution.
• Tiratam Vial Levetiracetam 500 mg / 5 ml anticonvulsant SV2A receptor blocker injection.
• Amipride 50 mg Tablets Amisulpride 50 mg antipsychotic medication for psychiatric conditions.
• Amipride 200 mg Tablets Amisulpride 200 mg antipsychotic medication for psychiatric conditions.
• Amipride 400 mg Tablets Amisulpride 400 mg antipsychotic medication for psychiatric conditions.
• Aripiprex 10 mg Tablets Aripiprazole 10 mg atypical antipsychotic for psychiatric conditions.
• Aripiprex 15 mg Tablets Aripiprazole 15 mg atypical antipsychotic for psychiatric conditions.
• Aripiprex 20 mg Tablets Aripiprazole 20 mg atypical antipsychotic for psychiatric conditions.
• Aripiprex 30 mg Tablets Aripiprazole 30 mg atypical antipsychotic for psychiatric conditions.
• Aripiprex 1 mg Oral Solution Aripiprazole 1 mg / ml atypical antipsychotic oral solution.
• Aripiprex 9.75 mg Vial Aripiprazole 9.75 mg / 1.3 ml atypical antipsychotic injection.
• Depretreve 30 mg D.R Capsules Duloxetine 30 mg delayed-release antidepressant for psychiatric conditions.
• Depretreve 60 mg D.R Capsules Duloxetine 60 mg delayed-release antidepressant for psychiatric conditions.
• Durazac Weekly Capsules Fluoxetine 90 mg antidepressant weekly capsules for psychiatric conditions.
• Tudasidone 40 mg Tablets Lurasidone HCl 40 mg atypical antipsychotic for psychiatric conditions.
• Tudasidone 80 mg Tablets Lurasidone HCl 80 mg atypical antipsychotic for psychiatric conditions.
• Andagra Tablets Sildenafil 100 mg erectile dysfunction treatment.
• Andodaricin Tablets Darifenacin 7.5 mg overactive bladder treatment.
• Erovanafil 200 mg Tablets Avanafil 200 mg erectile dysfunction treatment.
• Sildocare 8 mg Capsules Silodosin 8 mg treatment for benign prostatic hyperplasia.
• Tadalong 5 mg Tablets Tadalafil 5 mg benign prostatic hyperplasia treatment.
• Tadalong 20 mg Tablets Tadalafil 20 mg erectile dysfunction agent.
• Andouristat 80 mg Tablets Febuxostat 80 mg xanthine oxidase inhibitor for treatment of gout.
• Andouristat 120 mg Tablets Febuxostat 120 mg xanthine oxidase inhibitor for treatment of gout.
• Andodaclata 60 mg Tablets Daclatasvir 60 mg anti-viral for hepatitis-C treatment.
• Andohepasuvir 400 mg Tablets Sofosbuvir 400 mg anti-viral for hepatitis-C treatment.
• Talafovir Tablets Tenofovir Alafenamide 25 mg anti-viral for hepatitis-B treatment.
• New-Clav 375 mg Dispersible Tablets Amoxicillin 250 mg + Clavulanic Acid 125 mg anti-bacterial penicillin combination dispersible tablets.
• New-Clav 625 mg Dispersible Tablets Amoxicillin 500 mg + Clavulanic Acid 125 mg anti-bacterial penicillin combination dispersible tablets.
• New-Clav 1 gm Dispersible Tablets Amoxicillin 875 mg + Clavulanic Acid 125 mg anti-bacterial penicillin combination dispersible tablets.
• New-Clav 457 mg / 5 ml Powder for Oral Suspension Amoxicillin 400 mg + Clavulanic Acid 57 mg anti-bacterial penicillin combination oral suspension.
• New-Clav 642.9 mg / 5 ml Powder for Oral Suspension Amoxicillin 600 mg + Clavulanic Acid 42.9 mg anti-bacterial penicillin combination oral suspension.
• Bioglita Plus 15/500 mg Tablets Pioglitazone 15 mg + Metformin HCl 500 mg antidiabetic thiazolidinedione combination.
• Bioglita Plus 15/850 mg Tablets Pioglitazone 15 mg + Metformin HCl 850 mg antidiabetic thiazolidinedione combination.
• Glimepiride Plus 4/30 mg Tablets Glimepiride 4 mg + Pioglitazone 30 mg antidiabetic sulfonylurea combination.
• Brimondalous Topical Gel Brimonidine 3 mg / 1 gm topical gel for treatment of facial rosacea.
• Netlook 10 mg Capsules Isotretinoin 10 mg antiacne capsules inhibiting sebaceous gland function and keratinization.
• Netlook 20 mg Capsules Isotretinoin 20 mg antiacne capsules inhibiting sebaceous gland function and keratinization.
• Netlook 40 mg Capsules Isotretinoin 40 mg antiacne capsules inhibiting sebaceous gland function and keratinization.
• Performa Extra Strength 5% Topical Solution Minoxidil 5% (5 gm/100 ml) alopecia and hair regrowth topical solution.
• Tarolimus Ointment Tacrolimus 0.3 mg ointment for treatment of eczema.
• Zarotex Topical Gel Tazarotene 0.1 mg antiacne topical gel.
• Andomatoid 2 mg Tablets Baricitinib 2 mg immunosuppressive drug tablets.
• Andomatoid 4 mg Tablets Baricitinib 4 mg immunosuppressive drug tablets.
• Disprelone-OD 5 mg Oro-Dispersible Tablets Prednisolone 5 mg corticosteroid oro-dispersible tablets.
• Disprelone-OD 20 mg Oro-Dispersible Tablets Prednisolone 20 mg corticosteroid oro-dispersible tablets.
• Disprelone-D 20 mg Dispersible Tablets Prednisolone 20 mg corticosteroid dispersible tablets.
• Extragesic Tablets Dexibuprofen 400 mg analgesic and anti-inflammatory tablets.
• Ricoxitib 60 mg Tablets Etoricoxib 60 mg anti-inflammatory tablets.
• Ricoxitib 90 mg Tablets Etoricoxib 90 mg anti-inflammatory tablets.
• Erdolytic 300 mg Capsules Erdosteine 300 mg mucolytic capsules for respiratory conditions.
• Performa Hair Spray The company's first product, a hair regrowth spray that launched the company's product line.

Quantifiable outcome

• Top 20 pharmaceutical company in Egypt
• +1 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves5 records

Expansion highlights2 records

Direct peers

• EGY Pharma: Egyptian pharmaceutical manufacturer producing generics and OTC products for the local market. Comparable as a domestic mid-sized generics competitor targeting Egyptian physicians and pharmacies.
• EIPICO (Egyptian International Pharmaceutical Industries Company): Long-established Egyptian generic pharmaceutical manufacturer with broad therapeutic coverage and domestic manufacturing. A direct competitor operating in the same product categories, channels, and Egyptian regulatory environment.
• Mepaco Pharmaceuticals: Egyptian pharmaceutical manufacturer with a portfolio of branded generics and OTC products. Comparable in mid-sized domestic manufacturing scale and physician-targeted commercial approach.
• Pharco Pharmaceuticals: Egyptian pharmaceutical manufacturer ranked among the top domestic players, producing generics, branded drugs, and healthcare products. Comparable in therapeutic breadth, manufacturing footprint, and Egypt-centric sales model.
• AMOUN Pharmaceutical: Leading Egyptian pharmaceutical company producing branded generics across cardiovascular, CNS, anti-infectives and other therapeutic areas. Comparable in product positioning, target physicians, and Egypt-led sales motion.
• Eva Pharma: One of the largest Egyptian pharmaceutical manufacturers with broad generic and specialty portfolios across multiple therapeutic areas. Directly comparable as a domestic competitor targeting Egyptian physicians with branded generics and similar channel structure.

Regional players

• Julphar (Gulf Pharmaceutical Industries): Gulf-based pharmaceutical manufacturer with generic and consumer health portfolios primarily serving MENA markets. Comparable in regional generic manufacturing focus, though based in the UAE rather than Egypt.
• SPIMACO: Saudi-listed pharmaceutical manufacturer with broad generic and branded portfolios serving MENA. Comparable in regional manufacturing scale and multi-therapeutic coverage, though headquartered and primarily distributed in Saudi Arabia.
• Tabuk Pharmaceuticals: Saudi Arabian pharmaceutical manufacturer producing branded generics for MENA markets. Comparable in regional generic manufacturing strategy and therapeutic breadth, with geographic emphasis on the Arabian Peninsula.

Broad incumbents

• Hikma Pharmaceuticals: MENA-headquartered multinational pharmaceutical company with a broad generics and branded portfolio across the Middle East and Africa. Comparable in therapeutic breadth and regional distribution, but materially larger and operates across multiple geographies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Al Andalous Medical